Meshima (Phellinus linteus)
Explore mushroom research and guides on meshima (phellinus linteus).
Meshima for Chronic Inflammatory Conditions
Meshima research covers chronic inflammation across IBD, asthma, and allergy. Here's the evidence: animal models, 2024 colitis data, and two 2022 human RCTs.
Meshima vs. Other Anti-Cancer Mushrooms: Where It Fits
Meshima vs Turkey Tail vs Reishi vs Chaga: an honest comparison by evidence quality. Here's what each mushroom is actually evidence-based for and what makes Meshima unique.
Phellinus linteus Bioactive Compounds: How Each Class Works
Phellinus linteus contains polysaccharides and hispolon, two compound classes with different mechanisms. A 2023 systematic review confirmed five distinct biological functions. Here's how each works.
Phellinus linteus: Korea's Most Prized Medicinal Mushroom
Phellinus linteus (meshima): the 1968 screening that made its name, two 2022 CONSORT trials from one Korean group, and the species-identity problem buyers rarely hear about.
The History of Meshima in Korean Traditional Medicine
Meshima has been used in Korean medicine for 2,000 years. Learn the naming story, Ikekawa's 1970s screening breakthrough, and the species identity problem.
What Is Meshima Mushroom? Korea's Anti-Cancer Mushroom
Meshima mushroom (Phellinus linteus): 2,000-year Korean history, two 2022 CONSORT RCTs, hispolon anti-cancer compounds, and the species naming controversy.